The global medical scene is booming, spurred by rising chronic diseases and ageing populations. This fertile ground fosters innovation, particularly in the $512 billion medical device market. One rising star within this realm is the neurostimulator. These devices send electrical pulses to the brain or spinal cord, treating conditions like chronic pain, Parkinson’s, and depression. With a projected CAGR of 6.2%, the neurostimulator market is anticipated to reach $10.2 billion by 2028, reflecting its growing role in alleviating neurological burdens and reshaping the future of healthcare.
This device aims to revolutionize treatment approaches by incorporating non-invasive brain stimulation, EEG monitoring, Bluetooth Low Energy (BLE) connectivity, and personalized cognitive interventions. In this blog post, we’ll delve into the objectives, challenges, and comprehensive solutions offered by the SyrmaSGS, as well as its potential benefits and value addition to mental health treatment.
The Challenges:
A global leader in the business of unlocking brain potential through AI-powered neurostimulators approached Syrma SGS to develop an advanced neural stimulator to gain a competitive advantage in the market.
The primary goal of the neurostimulator is to create a device that encompasses several key functionalities, including non-invasive brain stimulation, EEG monitoring with high precision accuracy (for before & after stimulation), seamless BLE connectivity with a mobile app, behavioural therapy, and simple cognitive games. The device is designed to be battery-operated with low power consumption, utilizing the evolutionary Transcranial Direct Current Stimulation (tDCS).
Our holistic approach in crafting an advanced neural stimulator:
To address these challenges, SETS developed a holistic approach and delivered a comprehensive SETS solution by:
- Syrma SGS developed the industrial and mechanical design, enhancing device ergonomics for improved user experience and accessibility.
- Syrma SGS developed rigorous hardware design to improve reliability and performance also enabling all essential features and functionalities.
- Implemented highly accurate EEG monitoring capabilities (up to 95%) that are crucial to monitor the stimulator’s effectiveness.
- The prototyping and testing phases are implemented to enhance reliability and ensure customer safety. Subsequently, the neurostimulator undergoes mass production for wider accessibility.
Tailored stimulation, redefined: Emphasizing personalized treatment solutions
The neurostimulator offers a range of benefits and value additions to mental health treatment:
- Depression Treatment: The device introduces a novel approach to treating depression through Personalized Transcranial Direct Current Stimulation (tDCS). This provides a tailored stimulation based on individual needs, optimizing treatment outcomes by considering the unique characteristics of each user
- Superior Combined Therapy: The integration of non-invasive brain stimulation, EEG monitoring, BLE connectivity, behavioural therapy, and cognitive games results in a comprehensive and superior therapeutic approach.
The Future of Neural Stimulators:
Neural stimulators are surging beyond niche treatments, poised to reshape healthcare. The market, currently at $6 billion, is projected to grow 150% by 2028, driven by AI-powered personalization, wireless implants, and optogenetics. Imagine closed-loop systems that predict seizures and adjust stimulations in real-time, or ultra-fine electrodes targeting specific brain regions with laser precision. These advancements will not only treat chronic conditions like Parkinson’s and depression, but potentially enhance cognition, memory, and even learning. While ethical concerns loom, the future promises a world where neural stimulation not only alleviates suffering, but unlocks human potential beyond imagination
Empowering healthcare, with SyrmaSGS:
In conclusion, the development of this neurostimulator represents a significant leap forward in mental health technology. By tackling the challenges of non-invasive brain stimulation, EEG monitoring, BLE connectivity, and more, the neurostimulator is poised to make a lasting impact on the treatment of depression and related mental health conditions. With its innovative functionalities and personalized approach, it holds the potential to enhance the lives of individuals seeking effective and personalized mental health interventions.
SyrmaSGS empowers global manufacturers by providing reliable and sustainable solutions through comprehensive engineering, manufacturing, and testing expertise. The company’s emphasis on innovation positions it at the forefront of industry advancements, providing clients with a competitive edge. SyrmaSGS’s holistic approach to delivering quality solutions contributes to the success of manufacturers worldwide, fostering a collaborative and thriving relationship in the global market landscape. With a commitment to innovation, SyrmaSGS ensures the delivery of cutting-edge solutions that advance the time to market deploying cost-effective solutions, enabling businesses to thrive in the dynamic market.